Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Modulation of TARP γ8-Containing AMPA Receptors as a Novel Therapeutic Approach for Chronic Pain.

Knopp KL, Simmons RMA, Guo W, Adams BL, Gardinier KM, Gernert DL, Ornstein PL, Porter W, Reel J, Ding C, Wang H, Qian Y, Burris KD, Need A, Barth V, Swanson S, Catlow J, Witkin JM, Zwart R, Sher E, Choong KC, Wall TM, Schober D, Felder CC, Kato AS, Bredt DS, Nisenbaum ES.

J Pharmacol Exp Ther. 2019 Jun;369(3):345-363. doi: 10.1124/jpet.118.250126. Epub 2019 Mar 25.

PMID:
30910921
2.

Astrocytes modulate thalamic sensory processing via mGlu2 receptor activation.

Copeland CS, Wall TM, Sims RE, Neale SA, Nisenbaum E, Parri HR, Salt TE.

Neuropharmacology. 2017 Jul 15;121:100-110. doi: 10.1016/j.neuropharm.2017.04.019. Epub 2017 Apr 14.

3.

Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs.

Northrup NC, Gieger TL, Kosarek CE, Saba CF, LeRoy BE, Wall TM, Hume KR, Childress MO, Keys DA.

Vet Comp Oncol. 2009 Mar;7(1):38-44. doi: 10.1111/j.1476-5829.2008.00170.x.

PMID:
19222829
4.

Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonists.

Walker DP, Wishka DG, Piotrowski DW, Jia S, Reitz SC, Yates KM, Myers JK, Vetman TN, Margolis BJ, Jacobsen EJ, Acker BA, Groppi VE, Wolfe ML, Thornburgh BA, Tinholt PM, Cortes-Burgos LA, Walters RR, Hester MR, Seest EP, Dolak LA, Han F, Olson BA, Fitzgerald L, Staton BA, Raub TJ, Hajos M, Hoffmann WE, Li KS, Higdon NR, Wall TM, Hurst RS, Wong EH, Rogers BN.

Bioorg Med Chem. 2006 Dec 15;14(24):8219-48. Epub 2006 Oct 2.

PMID:
17011782
5.

Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship.

Wishka DG, Walker DP, Yates KM, Reitz SC, Jia S, Myers JK, Olson KL, Jacobsen EJ, Wolfe ML, Groppi VE, Hanchar AJ, Thornburgh BA, Cortes-Burgos LA, Wong EH, Staton BA, Raub TJ, Higdon NR, Wall TM, Hurst RS, Walters RR, Hoffmann WE, Hajos M, Franklin S, Carey G, Gold LH, Cook KK, Sands SB, Zhao SX, Soglia JR, Kalgutkar AS, Arneric SP, Rogers BN.

J Med Chem. 2006 Jul 13;49(14):4425-36.

PMID:
16821801
6.

A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.

Hurst RS, Hajós M, Raggenbass M, Wall TM, Higdon NR, Lawson JA, Rutherford-Root KL, Berkenpas MB, Hoffmann WE, Piotrowski DW, Groppi VE, Allaman G, Ogier R, Bertrand S, Bertrand D, Arneric SP.

J Neurosci. 2005 Apr 27;25(17):4396-405.

7.

Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors.

Bodnar AL, Cortes-Burgos LA, Cook KK, Dinh DM, Groppi VE, Hajos M, Higdon NR, Hoffmann WE, Hurst RS, Myers JK, Rogers BN, Wall TM, Wolfe ML, Wong E.

J Med Chem. 2005 Feb 24;48(4):905-8.

PMID:
15715459
10.

Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism.

Wall TM, Linseman DA, Hartman JC.

Eur J Pharmacol. 1996 Jun 13;306(1-3):165-74.

PMID:
8813629
11.

Protection of ischemic/reperfused canine myocardium by CL18/6, a monoclonal antibody to adhesion molecule ICAM-1.

Hartman JC, Anderson DC, Wiltse AL, Lane CL, Rosenbloom CL, Manning AM, Humphrey WR, Wall TM, Shebuski RJ.

Cardiovasc Res. 1995 Jul;30(1):47-54.

PMID:
7553723
12.

The trolox analog, U-78517F, attenuates hypoxic injury in isolated cardiac myocytes.

Linseman DA, Wall TM, Hartman JC.

J Mol Cell Cardiol. 1994 Sep;26(9):1249-57.

PMID:
7815467
13.

Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.

Hartman JC, Kurc GM, Hullinger TG, Wall TM, Sheehy RM, Shebuski RJ.

J Pharmacol Exp Ther. 1994 Sep;270(3):1071-6.

PMID:
7523655
14.

Role of bradykinin in myocardial preconditioning.

Wall TM, Sheehy R, Hartman JC.

J Pharmacol Exp Ther. 1994 Aug;270(2):681-9.

PMID:
8071859
15.

Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.

Hartman JC, Wall TM, Hullinger TG, Shebuski RJ.

J Cardiovasc Pharmacol. 1993 Jun;21(6):996-1003.

PMID:
7687728
16.

Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition.

Hartman JC, Hullinger TG, Wall TM, Shebuski RJ.

Eur J Pharmacol. 1993 Apr 6;234(2-3):229-36.

PMID:
8482328
17.

Clinicopathological conference. Case 20, part 2. Idiopathic gingival fibromatosis.

Yurosko JJ, Wall TM, Vopal JJ, Gossman JR.

J Oral Surg. 1977 Nov;35(11):907-8. No abstract available.

PMID:
269934
18.

Clinicopathological conference. Case 20, part 1.

Yurosko JJ, Wall TM, Vopal JJ, Gossman JR.

J Oral Surg. 1977 Oct;35(10):820-2. No abstract available.

PMID:
269232

Supplemental Content

Support Center